First human trial of FMT for obesity concludes unfavorably

“The results from the first randomized controlled human trial into [Fecal Matter Transplants] for obesity suggest modulating the microbiome of humans to treat obesity may be more complicated than researchers had hoped.” Although it worked in animal models, it didn’t show hoped-for effects in humans. learn more

Leave a Reply

Your email address will not be published. Required fields are marked *